Loading...

Loading...

Fires, Sleep Studies, Legislative Actions: The Week in Health
By Sofía Garduño - Thu, 04/04/2024 - 10:00
Mexico faces wildfires, deep sleep aids dementia prevention, and PAN pushes for biodegradable filters. This is The Week in Health!

https://mexicobusiness.news/tag/roche
More Health
Roche's Malaria Test is Granted FDA Approval
By MBN Staff - Tue, 04/02/2024 - 14:03
Roche's cobas Malaria test receives FDA approval, a tool poised to help enhance blood safety.

Health in the Americas: Cardiovascular Risk, Worm Treatments
By Sofía Garduño - Thu, 02/08/2024 - 10:00
PAHO published a guide for managing cardiovascular risks, and J&J extended its initiative donating products for treating intestinal worms.
Digital Solutions Will Revolutionize Healthcare
By Anmol Motwani - Tue, 02/06/2024 - 11:43
Digital health solutions empower individuals, reduce redundancy in medical tests, and enhance efficiency, says Rolf Hoenger,Head of Roche Pharma LATAM
Primary Care, Well-being in Focus: The Week in Health
By Sofía Garduño - Thu, 07/27/2023 - 10:00
This week, CONASAMA promoted self-care while PAHO highlighted the importance of primary care in achieving universal healthcare coverage.
Johnson & Johnson Becomes Most Valuable Pharma Brand of 2023
By Sofía Garduño - Thu, 07/20/2023 - 11:52
Brand Finance's healthcare report names Johnson & Johnson as the most valuable brand worldwide.
Collaboration, Digitization Crucial for Oncology Innovation
By Antonio Gozain - Thu, 09/01/2022 - 10:20
From regulatory obstacles to a fragmented healthcare system, Mexico faces several challenges to offer innovative cancer treatments.
Early Diagnosis Essential for Lung Cancer Treatment
By Miriam Bello - Tue, 08/30/2022 - 08:49
Early diagnosis reduces treatment costs and increases life expectancy, says Isabela Rivas, Medical Value Lead Lung Cancer, Roche México.
Bio Convention an Opportunity to Demonstrate Mexico’s Potential
By Victor Gabriel Sánchez - Wed, 06/29/2022 - 10:00
Ahead of the annual global bio convention, Victor Sanchez explains the opportunity for Mexico in this growing industry.
Roche’s New Cancer Immunotherapy Fails in first Late-Stage Trial
By Antonio Gozain - Thu, 03/31/2022 - 13:32
Roche said that tiragolumab, combined with its established cancer drug Tecentriq and chemotherapy, failed to reduce the rate of disease progression.